Retraction
Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19
Paper Information
Record ID:
38876
Author(s):
Publication Date:
June 03, 2022
Retraction Date:
August 31, 2022
(3.2 years years ago)
Subjects:
Institutions:
- Department of Basic Sciences and Social Sciences, North-Eastern Hill University, Shillong, Meghalaya, India
- Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia
- Department of Environment and Forest Resources, Chungnam National University, Daejeon, Republic of Korea
Countries:
Article Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1371/journal.pone.0273489Citations (8)
8
Total Citations6
Post-Retraction(75.0%)
0
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
2
After 2+ years
1004
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Design and in Silico evaluation of 3’,4’-Dimethoxy flavonol as promising SARS-CoV-2 main protease (Mpro) inhibitor
Neni Frimayanti, Ihsan Ikhtiarudin, Roni Ardiyansyah et al. (5 authors)
In Silico Pharmacology
Published: May 2025
1004 days after retraction
Exploration of plant alkaloids as potential inhibitors of <i>HIV</i>–CD4 binding: Insight into comprehensive <i>in silico</i> approaches
Imran Zafar, Zain Abbas, Sidra Abbas et al. (7 authors)
Open Chemistry
Open Access
Published: Jan 2025
854 days after retraction
6-Octadecenoic and Oleic Acid in Liquid Smoke Rice Husk Showed COVID-19 Inhibitor Properties
Ira Arundina, Neni Frimayanti, Meircurius Dwi Condro Surboyo et al. (5 authors)
Advances in Pharmacological and Pharmaceutical Sciences
Open Access
Published: Apr 2024
4 citations
4 citations
603 days after retraction
Exploring Substituted Tetrazoloquinazoline: Biological Activities, Molecular Docking Analysis, and Anti‐Breast Cancer MCF7/HER2 Effects
Neni Frimayanti, Ihsan Ikhtiarudin, Rahma Dona et al. (5 authors)
Advances in Pharmacological and Pharmaceutical Sciences
Open Access
Published: Jan 2024
1 citation
1 citation
488 days after retraction
Proteins and Peptides-Based Antibacterial and Antiviral Materials
Mandana Lak, Iman Zare, Hamid Rashedi et al. (6 authors)
ACS symposium series
Published: Dec 2023
1 citation
1 citation
469 days after retraction
Virtual screening of knottin and defensin peptides perceives hits against the SARS CoV-2 RBD domain and hACE2 interaction
Nitesh Mani Tripathi, Anupam Bandyopadhyay
Unknown Journal
Open Access
Published: Jan 2023
1 citation
1 citation
140 days after retraction
Retraction: Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19
Unknown Authors
PLoS ONE
Open Access
Published: Aug 2022
Same day as retraction
Quick Stats
Total Citations:
12
Years Since Retraction:
3.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025